GaryFanjiangMDMBA, MS
Pediatric Gastroenterology • Wilmington, DEDivisional Vice President, Scientific & Medical Affairs, Abbott Nutrition
Dr. Fanjiang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1800 Concord Pike
Wilmington, DE 19897- Is this information wrong?
Education & Training
Tufts Medical CenterResidency, Peds/Psych/Child-Adolescent Psych, 2000 - 2002
Tufts University School of MedicineClass of 2000
Certifications & Licensure
DE State Medical License 2007 - 2025
MA State Medical License 2004 - 2007
Publications & Presentations
PubMed
- 13 citationsComparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritisMark C. Genovese, Juan Sánchez-Bursón, MyungShin Oh, Éva Balázs, Jeffrey Neal, Andrea Everding, Tomas Hala, Rafal Wojciechowski, Gary Fanjiang, Stanley Cohen> ;Arthritis Research & Therapy. 2020 Mar 26
- 6 citationsPharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single-Blind, Single-Dose, Parallel-Group Study in Healthy Subje...Vincent Chow, MyungShin Oh, Melissa A. Gessner, Gary Fanjiang> ;Clinical Pharmacology in Drug Development. 2019 Oct 19
- 21 citationsA Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501Richard Markus, Helen J. McBride, Monica Ramchandani, Vincent Chow, Jennifer Liu, Dan Mytych, Gary Fanjiang> ;Advances in Therapy. 2019 Jun 10
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
